Blog
RSS FeedPosted by Michael Wonder on 19 Oct 2019
Merck receives EU CHMP positive opinion for investigational V920 Ebola Zaire vaccine for protection against Ebola virus disease
18 October 2019 - Merck today announced that the CHMP of the EMA has adopted a positive opinion recommending a conditional ...
Posted by Michael Wonder on 17 Oct 2019
Complexity in assessing the benefit versus risk of vaccines: experience with rotavirus and dengue virus vaccines
17 October 2019 - The remarkable contribution of immunisation programs to public health is recognised by most people, including those who ...
Posted by Michael Wonder on 16 Oct 2019
First Algenex CrisBio-based vaccine submitted to European Medicines Agency
15 October 2019 - Potential approval would validate the use of Algenex’ CrisBio technology for the manufacture of recombinant subunit vaccines. ...
Posted by Michael Wonder on 10 Oct 2019
Emergent BioSolutions receives EMA Prime Designation for its Chikungunya virus vaccine candidate
10 October 2019 - Emergent BioSolutions today announced that the company’s chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, ...
Posted by Michael Wonder on 25 Sep 2019
FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox
24 September 2019 - The U.S. FDA announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
Posted by Michael Wonder on 17 Sep 2019
FDA accepts Merck’s biologics license application and grants priority review for V920, the company’s investigational vaccine for Ebola Zaire virus
17 September 2019 - Merck continues to expand investigational supply to support international Ebola outbreak response. ...
Posted by Michael Wonder on 17 Sep 2019
I'm not in ...some Third World place': bladder cancer patients face ongoing scarcity of life-saving drug
16 September 2019 - Canada's only supplier, Merck, is now projecting BCG shortage will last until December 2020. ...
Posted by Michael Wonder on 09 Sep 2019
FDA reiterates the importance of vaccines such as the Measles, Mumps, and Rubella (MMR) vaccine
6 September 2019 - The U.S. continues to experience cases and outbreaks of measles, largely due to unvaccinated or under-vaccinated segments ...
Posted by Michael Wonder on 03 Sep 2019
Janssen announces U.S. FDA breakthrough therapy designation for investigational prophylactic vaccine for the prevention of respiratory syncytial virus in older adults
3 September 2019 - Janssen announced today that the U.S. FDA has granted breakthrough therapy designation for the Company's investigational ...
Posted by Michael Wonder on 20 Aug 2019
Moderna receives FDA fast track designation for Zika vaccine mRNA-1893
19 August 2019 - Moderna today announced that the U.S. FDA has granted fast track designation for its investigational Zika vaccine ...
Posted by Michael Wonder on 04 Aug 2019
Vas Narasimhan of Novartis: ‘we are not at all prepared for a pandemic’
1 August 2019 - The son of Indian immigrants read Greek philosophy and worked at McKinsey before joining a giant drug ...
Posted by Michael Wonder on 17 Jul 2019
Trump to order drive for improved flu vaccine
16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...
Posted by Michael Wonder on 21 May 2019
New made-in-Canada technique could revolutionise vaccine transportation
21 May 2019 - Researchers in Ontario have developed a new method of transporting life-saving vaccines to remote and impoverished ...
Posted by Michael Wonder on 21 May 2019
Emergent BioSolutions announces granting of marketing authorisation in Five EU countries for its oral typhoid vaccine; expands availability across Europe
20 May 2019 - Emergent BioSolutions announced today that it has successfully obtained marketing authorization for its oral typhoid vaccine Vivotif ...
Posted by Michael Wonder on 02 May 2019
First FDA approved vaccine for the prevention of dengue disease in endemic regions
1 May 2019 - The U.S. FDA announced today the approval of Dengvaxia, the first vaccine approved for the prevention of ...